Studies of the mouse kappa opioid receptor gene
小鼠κ阿片受体基因的研究
基本信息
- 批准号:6864823
- 负责人:
- 金额:$ 12.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-04-01 至 2007-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (provided by the applicant)
The purpose of this K02 application is to seek salary support for scientific
career development of the PI at the Dept. Pharmacology of Univ. Minnesota
Medical School. The PI was trained in molecular biology and genetics with
special focus on interaction of hormone nuclear receptors and transcription
factors. She has initiated a research project (DA-11190) aimed to study
regulatory mechanisms for kappa opioid receptor (KOR) gene regulation. In order
to develop her sceintific career along the line of drug abuse research and
perform several experiments described in this project, she plans to devote more
time into her research and receive further training in developmental
neurobiology and opioid pharmacology. The project proposed is based upon the
currently funded R01 to examine several important regulatory mechanisms
underlying KOR gene expression. Three aims are proposed to address two
fundamental problems in KOR gene regulation: transcription and
post-transcriptional mechanisms for controlling KOR expression. Three aims are:
1)To Study Transcriptional Regulation of Mouse KOR Gene, 2) To Study
Post-transcriptional Regulation of Mouse KOR Expression and 3) Transgenic Mouse
Models to Study KOR Ontogeny and Regulation. The first aim will address
transcriptional control by focusing on a retinoic acid (RA)-regulated silencer
element located in intron 1 of the gene, and the positive mechanisms regulating
promoters 1 and 2. The mechanisms underlying histone deacetylation on KOR
promoters as a result of retinoid depletion will be addressed. Protein factors
responsible for the activation of KOR gene in KOR neurons will be identified.
An embryonic cell line P19 that is capable of differentiation into various cell
lineages including KOR neurons and expresses KOR in an RA-regulated manner will
be used. In the second aim, mRNA transport and protein translation efficiency
will be examined in relation to the cell- and tissue type-specificity of KOR
expression. The information gathered from aims 1 and 2 deals with KOR
regulation in vitro. The third aim is to confirm and correct the information
generated from in vitro models by using transgenic mouse models. These genetic
studies will answer whether and how pharmacological problems, such as opioid
addiction and tolerance, may be related to the endocrine system such as
retinoid status and the homeostatic control of opioid receptor gene activity.
The granting of this award will enable the PI to devote more time into her
research projects and take leave of absence to receive training. This award is
essential for the PI?s career development as a more productive and contributing
scientist in the field of drug abuse research.
描述:(申请人提供)
本次K02申请的目的是寻求对科学技术人员的薪酬支持
私隐专员在部门的职业发展。大学药理学。明尼苏达州
医学院。PI接受了分子生物学和遗传学方面的培训
特别关注激素核受体与转录的相互作用
各种因素。她发起了一个研究项目(DA-11190),旨在研究
Kappa阿片受体(KOR)基因调控机制。按顺序
沿着药物滥用研究和研究的方向发展她的科学生涯
进行了这个项目中描述的几个实验,她计划投入更多
投入到她的研究中,并接受了进一步的发展培训
神经生物学和阿片类药物药理学。建议的项目是基于
目前由R01资助,以检查几个重要的监管机制
潜在的KOR基因表达。提出了三个目标来解决两个问题
KOR基因调控的基本问题:转录和
控制KOR表达的转录后机制。三个目标是:
1)研究小鼠KOR基因的转录调控;2)研究
小鼠KOR表达的转录后调控及3)转基因小鼠
研究KOR个体发生和调节的模型。第一个目标将解决
对视黄酸(RA)调节的沉默因子的转录调控
位于该基因内含子1的元件及其正向调控机制
启动子1和2:KOR中组蛋白去乙酰化的机制
将解决由于维甲酸耗竭而导致的启动子问题。蛋白质因子
在KOR神经元中激活KOR基因的责任将被确定。
一种可分化为多种细胞的胚胎细胞系P19
包括KOR神经元和以RA调节的方式表达KOR的谱系将
被利用。在第二个目标中,信使核糖核酸转运和蛋白质翻译效率
将根据KOR的细胞和组织类型特异性进行检查
表情。从AIMS 1和AIMS 2收集的信息涉及KOR
体外调节。第三个目标是确认和纠正信息
通过使用转基因小鼠模型从体外模型中产生。这些基因
研究将回答是否以及如何解决药理学问题,如阿片类药物
成瘾和耐受,可能与内分泌系统有关,如
维甲酸状态和阿片受体基因活性的动态平衡控制。
授予这一奖项将使私人侦探能够花更多的时间在她身上
研究项目和请假接受培训。这个奖项是
对于皮埃尔?S的职业发展至关重要,成为一名更有成效和贡献的人
毒品滥用研究领域的科学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Li-Na Wei其他文献
Li-Na Wei的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Li-Na Wei', 18)}}的其他基金
Studies of nuclear receptor corepressor, NRIP1, in vitamin A signaling pathways
核受体辅阻遏物 NRIP1 在维生素 A 信号通路中的研究
- 批准号:
8007006 - 财政年份:2010
- 资助金额:
$ 12.36万 - 项目类别:
TR2 nuclear receptor in vitamin A signaling
维生素 A 信号转导中的 TR2 核受体
- 批准号:
8010070 - 财政年份:2010
- 资助金额:
$ 12.36万 - 项目类别:
Molecular Mechanisms of Ontogenesis of K-Opioid Receptors
K-阿片受体个体发生的分子机制
- 批准号:
7612853 - 财政年份:2008
- 资助金额:
$ 12.36万 - 项目类别:
Studies of the Mouse Kappa Opioid Receptor Gene
小鼠 Kappa 阿片受体基因的研究
- 批准号:
7599011 - 财政年份:2007
- 资助金额:
$ 12.36万 - 项目类别:
Studies of the Mouse Kappa Opioid Receptor Gene
小鼠 Kappa 阿片受体基因的研究
- 批准号:
7802336 - 财政年份:2007
- 资助金额:
$ 12.36万 - 项目类别:
Mechanisms of Ontogenesis of Kappa Opioid Receptors
Kappa 阿片受体的个体发生机制
- 批准号:
7513843 - 财政年份:2007
- 资助金额:
$ 12.36万 - 项目类别:
Studies of the Mouse Kappa Opioid Receptor Gene
小鼠 Kappa 阿片受体基因的研究
- 批准号:
7190873 - 财政年份:2007
- 资助金额:
$ 12.36万 - 项目类别:
Studies of the Mouse Kappa Opioid Receptor Gene
小鼠 Kappa 阿片受体基因的研究
- 批准号:
7409730 - 财政年份:2007
- 资助金额:
$ 12.36万 - 项目类别:
Studies of the Mouse Kappa Opioid Receptor Gene
小鼠 Kappa 阿片受体基因的研究
- 批准号:
8040951 - 财政年份:2007
- 资助金额:
$ 12.36万 - 项目类别:














{{item.name}}会员




